
Ionis CEO Brett P. Monia Prestigiously Honored with the 2025 Lifetime Achievement Award
Honored with the Achievement Award by the Oligonucleotide Therapeutics Society for pioneering leadership in RNA-targeted therapeutics. Ionis Pharmaceuticals, Inc. today announced that Brett P. Monia, Ph.D., Ionis’ chief executive officer, was awarded the 2025 Lifetime Achievement Award from the Oligonucleotide Therapeutics Society (OTS),…












